Evidence of neurodegeneration in autism spectrum disorder
about
Relevance of Neuroinflammation and Encephalitis in AutismCurcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's diseaseA common molecular signature in ASD gene expression: following Root 66 to autismAn evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autismAtypical miRNA expression in temporal cortex associated with dysregulation of immune, cell cycle, and other pathways in autism spectrum disordersMeasles-mumps-rubella vaccination timing and autism among young African American boys: a reanalysis of CDC dataStereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellumCo-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRPA two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum.Medicinal Plants of the Australian Aboriginal Dharawal People Exhibiting Anti-Inflammatory Activity.Recent updates in the treatment of neurodegenerative disorders using natural compounds.Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders.The complex genetics in autism spectrum disorders.A Multi-target Small Molecule for Targeted Transcriptional Activation of Therapeutically Significant Nervous System Genes.Saccadic eye movements in adults with high-functioning autism spectrum disorder.Significant Changes in Plasma Alpha-Synuclein and Beta-Synuclein Levels in Male Children with Autism Spectrum Disorder.
P2860
Q26772834-7AC295B4-AAEB-4D22-B58D-9C2B94E0E609Q26781090-E15E293D-915A-48CA-866E-F1AAEF2C0BFEQ28077428-9841569F-613B-42F5-BF96-B81BD169E4ACQ28655923-FDBE1480-BEB5-4895-830C-DBD3AD002AEAQ30656632-0EF63C60-61D0-4F50-BC3E-B26DA33CC85BQ30842179-C3CE9C50-3F0D-4C0F-84E9-FBE3D92BA11CQ34254256-A6F7A8B2-27D7-47AD-B54F-DAECFDF6E518Q37355103-1D30F8C7-D678-407B-A9A0-622E7111736AQ37425919-DB5A79CD-5BFA-43F8-8DEC-CEE03A124872Q37557777-B79E4157-72A9-4FDC-BC91-A58DB7A0C298Q37575436-84AD20DE-1D37-45ED-A3E2-E3FB57868B4AQ38215181-6C2B7AAC-6570-42F4-8C4F-3A74D095175AQ38365159-7CC8F3AB-553B-4BAE-B489-8E5AD5D2D56AQ38579867-C2A8E7D2-B5D4-4B30-9719-5D5B5E0925F1Q39340513-78C78954-7361-4706-99AB-33226442A7C0Q50418499-54B500AE-3CAD-48D3-A28B-4EB3EED921CAQ55511344-08473DB7-206E-42CB-B3C9-16C7F8966F90
P2860
Evidence of neurodegeneration in autism spectrum disorder
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence of neurodegeneration in autism spectrum disorder
@en
Evidence of neurodegeneration in autism spectrum disorder.
@nl
type
label
Evidence of neurodegeneration in autism spectrum disorder
@en
Evidence of neurodegeneration in autism spectrum disorder.
@nl
prefLabel
Evidence of neurodegeneration in autism spectrum disorder
@en
Evidence of neurodegeneration in autism spectrum disorder.
@nl
P2860
P50
P356
P1476
Evidence of neurodegeneration in autism spectrum disorder
@en
P2860
P2888
P356
10.1186/2047-9158-2-17
P577
2013-08-08T00:00:00Z
P5875
P6179
1028150734